Du
Duke Cancer Institute
NPDurham NCFounded 19724,000 employees
Private CapacadPrivateOncology
Platform: Cancer Center
Market Cap
N/A
All Drugs
4
Clinical Trials
4
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| DUK-IIT-810 | DUK-IIT-810 | Phase 1/2 | 1 | PD-1 | Psoriasis | ||
| DUK-IIT-134 | DUK-IIT-134 | Phase 2/3 | 1 | IL-23 | MG | ||
| DUK-IIT-253 | DUK-IIT-253 | Phase 1 | 1 | TROP-2 | DLBCL | ||
| DUK-IIT-841 | DUK-IIT-841 | Phase 1 | 1 | C5 | ADPKD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (1)